Global Liver Disease Therapeutic Market Analysis
The Global Liver Disease Therapeutic Market is experiencing steady growth and is projected to reach US$ 28.98 billion by 2032, up from US$ 13.86 billion in 2023. This growth represents a CAGR of 8.54% from 2024 to 2032, highlighting the increasing demand and potential in the field of liver disease treatment.
The liver is a crucial organ that plays a vital role in overall health. It is possible to target the liver effectively using genetic strategies with high liver tropism, including gene addition/editing and silencing, to address a wide range of diseases. Through gene addition and editing techniques, promising results have been observed in clinical trials, showing potential in overcoming challenges related to immune response and long-term stability. In addition, mRNA therapy has emerged as an innovative approach with demonstrated potential in treating liver-related disorders. The use of siRNAs and antisense oligonucleotides for gene sil